| Literature DB >> 27987857 |
Azadeh Haeri1, Saeed Sadeghian2, Shahram Rabbani2, Maryam Sotoudeh Anvari2, Samaneh Ghassemi1, Fatemeh Radfar2, Simin Dadashzadeh3.
Abstract
Assuring the efficient local delivery via biocompatible nanosystems can be considered as a promising therapy for restenosis. The aim of the present study was preparation, in vitro characterization, and in vivo efficacy evaluation of sirolimus containing chitosan decorated liposomes for restenosis treatment. Liposomes were coated with chitosan, leading to ∼38nm increase in the particle size and a positive shift in the zeta potential from -1mV to +21mV. Chitosan modification was also confirmed by TEM, increased stability against detergent solubilization, and FTIR analyses. High entrapment efficiency (≥83%) and sustained release behaviors were demonstrated in both coated and uncoated vesicles. Compared to control groups, treatment of balloon injured rats with uncoated and chitosan-coated liposomes (50μg sirolimus) significantly reduced stenosis by 39% and 62%, respectively. The effect was also confirmed by immunohistochemical and in vivo CT angiography imaging studies. Chitosan-coated liposomes could be a novel platform for restenosis treatment.Entities:
Keywords: Chitosan; Liposome; Local delivery; Restenosis; Sirolimus
Mesh:
Substances:
Year: 2016 PMID: 27987857 DOI: 10.1016/j.carbpol.2016.11.021
Source DB: PubMed Journal: Carbohydr Polym ISSN: 0144-8617 Impact factor: 9.381